By Marlene Kennedy/The Leader-Herald The culture wars over the Supreme Court’s reversal of Roe v. Wade hit public company boardrooms this spring meeting season. A record 30 proxy proposals on reproductive health were submitted for 2023 shareholder votes at annual meetings, double the number la